| Tn | <abbreviation> Ocular tension. (05 Mar 2000) |
|---|---|
| TNF | <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin. Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine. Synonym: cachectin. Acronym: TNF (13 Nov 1997) |
| TNF-IL1-activated protein kinase | <enzyme> Phosphorylates beta casein in vitro; not the same as casein kinase 1 and casein kinase 2; not activated by mitogens, celllular stresses or any other cytokines than il1 and tnf Registry number: EC 2.7.1.- Synonym: tip kinase, beta casein kinase (26 Jun 1999) |
| TNM | <abbreviation> Tumour-node-metastasis. See: TNM staging. (05 Mar 2000) |
| TNM classification | TNM classification provides a system for staging the occurrence of cancer., T refers to the primary tumour and is categorised as being 1-4 and a-d depending upon site, size and spread, N refers to the lymph nodes and they are categorised as being X,0, 1, 2, or 3 depending upon if any, some or all are involved metastasis, and M to the presence or absence of distant metasteses. Refer Staging. (16 Dec 1997) |
| TNM staging | A system of clinicopathologic evaluation of tumours based on the extent of tumour involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment. (05 Mar 2000) |
| tnpI recombinase | <enzyme> From tn2i and related beta-lactamase transposons Registry number: EC 2.7.7.- (26 Jun 1999) |
| TNT | <abbreviation> Trinitrotoluene. (05 Mar 2000) |